Works matching AU Ozaka, Masato

Results: 97
    1

    Retrospective study of RAS/PIK3CA/BRAF tumor mutations as predictors of response to first-line chemotherapy with bevacizumab in metastatic colorectal cancer patients.

    Published in:
    2017
    By:
    • Izuma Nakayama;
    • Eiji Shinozaki;
    • Tomohiro Matsushima;
    • Takeru Wakatsuki;
    • Mariko Ogura;
    • Takashi Ichimura;
    • Masato Ozaka;
    • Daisuke Takahari;
    • Mitsukuni Suenaga;
    • Keisho Chin;
    • Nobuyuki Mizunuma;
    • Kensei Yamaguchi;
    • Nakayama, Izuma;
    • Shinozaki, Eiji;
    • Matsushima, Tomohiro;
    • Wakatsuki, Takeru;
    • Ogura, Mariko;
    • Ichimura, Takashi;
    • Ozaka, Masato;
    • Takahari, Daisuke
    Publication type:
    journal article
    2
    3
    4

    Complete response of a pancreatic adenosquamous carcinoma to chemoradiotherapy.

    Published in:
    International Journal of Clinical Oncology, 2008, v. 13, n. 1, p. 74, doi. 10.1007/s10147-007-0690-x
    By:
    • Shibagaki, Kotaro;
    • Fujita, Koichi;
    • Nakayama, Shinji;
    • Takenaka, Mamoru;
    • Fukuba, Nobuhiko;
    • Matsui, Saori;
    • Ozaka, Masato;
    • Yoshinaga, Hiroshi;
    • Masuzawa, Akira;
    • Watanabe, Akihiko;
    • Fujiwara, Hitoshi;
    • Sugawara, Atsushi;
    • Fujita, Tsuyoshi;
    • Mukai, Hidekazu;
    • Kinoshita, Yoshikazu
    Publication type:
    Article
    5
    6

    Assessment of heterogeneity according to hospital or medical experience factors in outcomes of chemotherapy for advanced biliary tract cancer: a post-hoc analysis of JCOG1113.

    Published in:
    Japanese Journal of Clinical Oncology, 2025, v. 55, n. 4, p. 355, doi. 10.1093/jjco/hyae188
    By:
    • Fukushi, Koh;
    • Imaoka, Hiroshi;
    • Ikeda, Masafumi;
    • Mizusawa, Junki;
    • Morizane, Chigusa;
    • Okusaka, Takuji;
    • Kobayashi, Satoshi;
    • Sasahira, Naoki;
    • Shimizu, Satoshi;
    • Yamazaki, Kentaro;
    • Okano, Naohiro;
    • Miwa, Haruo;
    • Hara, Kazuo;
    • Satoi, Sohei;
    • Sano, Keiji;
    • Sakai, Kenji;
    • Sugimoto, Rie;
    • Nakamura, Kazuyoshi;
    • Terashima, Takeshi;
    • Ozaka, Masato
    Publication type:
    Article
    7

    Protocol digest of a randomized phase III trial comparing S-1-based chemoradiotherapy with/without nivolumab for unresectable locally advanced or borderline resectable pancreatic cancer: JCOG1908E (PENETRATE).

    Published in:
    Japanese Journal of Clinical Oncology, 2024, v. 54, n. 11, p. 1214, doi. 10.1093/jjco/hyae084
    By:
    • Sano, Yusuke;
    • Kanai, Masashi;
    • Morizane, Chigusa;
    • Sasaki, Keita;
    • Yoshimura, Michio;
    • Ito, Yoshinori;
    • Furuse, Junji;
    • Ozaka, Masato;
    • Fukuda, Haruhiko;
    • Ueno, Makoto;
    • Group, on behalf of the Hepatobiliary and Pancreatic Oncology Group in Japan Clinical Oncology
    Publication type:
    Article
    8

    Bone loss over time and risk of osteoporosis in advanced pancreatic cancer.

    Published in:
    Japanese Journal of Clinical Oncology, 2024, v. 54, n. 6, p. 667, doi. 10.1093/jjco/hyae028
    By:
    • Takeda, Tsuyoshi;
    • Sasaki, Takashi;
    • Okamoto, Takeshi;
    • Hirai, Tatsuki;
    • Ishitsuka, Takahiro;
    • Yamada, Manabu;
    • Nakagawa, Hiroki;
    • Furukawa, Takaaki;
    • Mie, Takafumi;
    • Kasuga, Akiyoshi;
    • Ozaka, Masato;
    • Sasahira, Naoki
    Publication type:
    Article
    9

    Outcomes of lung oligometastasis in pancreatic cancer.

    Published in:
    Japanese Journal of Clinical Oncology, 2023, v. 53, n. 12, p. 1144, doi. 10.1093/jjco/hyad111
    By:
    • Takeda, Tsuyoshi;
    • Sasaki, Takashi;
    • Ichinose, Junji;
    • Inoue, Yosuke;
    • Okamoto, Takeshi;
    • Mie, Takafumi;
    • Furukawa, Takaaki;
    • Kasuga, Akiyoshi;
    • Oba, Atsushi;
    • Matsuura, Yosuke;
    • Nakao, Masayuki;
    • Ozaka, Masato;
    • Mun, Mingyon;
    • Takahashi, Yu;
    • Sasahira, Naoki
    Publication type:
    Article
    10
    11

    Comprehensive review of undifferentiated carcinoma of the pancreas: from epidemiology to treatment.

    Published in:
    Japanese Journal of Clinical Oncology, 2023, v. 53, n. 9, p. 764, doi. 10.1093/jjco/hyad062
    By:
    • Imaoka, Hiroshi;
    • Ikeda, Masafumi;
    • Umemoto, Kumiko;
    • Sunakawa, Yu;
    • Ueno, Makoto;
    • Ueno, Hideki;
    • Ozaka, Masato;
    • Kuwahara, Takamichi;
    • Okano, Naohiro;
    • Kanai, Masashi;
    • Hisano, Terumasa;
    • Suzuki, Yuko;
    • Asagi, Akinori;
    • Shioji, Kazuhiko;
    • Todaka, Akiko;
    • Tsuji, Kunihiro;
    • Ikezawa, Kenji;
    • Miki, Ikuya;
    • Komatsu, Yoshito;
    • Akutsu, Noriyuki
    Publication type:
    Article
    12

    Effect of systemic inflammatory response on induction chemotherapy followed by chemoradiotherapy for locally advanced pancreatic cancer: an exploratory subgroup analysis on systemic inflammatory response in JCOG1106.

    Published in:
    Japanese Journal of Clinical Oncology, 2023, v. 53, n. 8, p. 704, doi. 10.1093/jjco/hyad044
    By:
    • Mizuno, Nobumasa;
    • Ioka, Tatsuya;
    • Ogawa, Gakuto;
    • Nakamura, Satoaki;
    • Hiraoka, Nobuyoshi;
    • Ito, Yoshinori;
    • Katayama, Hiroshi;
    • Takada, Ryoji;
    • Kobayashi, Satoshi;
    • Ikeda, Masafumi;
    • Miwa, Haruo;
    • Okano, Naohiro;
    • Kuramochi, Hidekazu;
    • Sekimoto, Mitsugu;
    • Okusaka, Takuji;
    • Ozaka, Masato;
    • Todaka, Akiko;
    • Gotoh, Kunihito;
    • Tobimatsu, Kazutoshi;
    • Yamaguchi, Hironori
    Publication type:
    Article
    13

    Protocol of a randomized phase II/III study of gemcitabine plus nab-paclitaxel combination therapy versus modified FOLFIRINOX versus S-IROX for metastatic or recurrent pancreatic cancer: JCOG1611 (GENERATE).

    Published in:
    Japanese Journal of Clinical Oncology, 2023, v. 53, n. 1, p. 80, doi. 10.1093/jjco/hyac146
    By:
    • Mizusawa, Junki;
    • Ohba, Akihiro;
    • Ozaka, Masato;
    • Katayama, Hiroshi;
    • Okusaka, Takuji;
    • Kobayashi, Satoshi;
    • Ikeda, Masafumi;
    • Terashima, Takeshi;
    • Sasahira, Naoki;
    • Okano, Naohiro;
    • Miki, Ikuya;
    • Kaneko, Takashi;
    • Mizuno, Nobumasa;
    • Todaka, Akiko;
    • Furukawa, Masayuki;
    • Kajiura, Shinya;
    • Kataoka, Tomoko;
    • Fukuda, Haruhiko;
    • Furuse, Junji;
    • Ueno, Makoto
    Publication type:
    Article
    14
    15
    16
    17
    18

    Randomized phase II study of chemoradiotherapy with versus without induction chemotherapy for locally advanced pancreatic cancer: Japan Clinical Oncology Group trial, JCOG1106.

    Published in:
    Japanese Journal of Clinical Oncology, 2021, v. 51, n. 2, p. 235, doi. 10.1093/jjco/hyaa198
    By:
    • Ioka, Tatsuya;
    • Furuse, Junji;
    • Fukutomi, Akira;
    • Mizusawa, Junki;
    • Nakamura, Satoaki;
    • Hiraoka, Nobuyoshi;
    • Ito, Yoshinori;
    • Katayama, Hiroshi;
    • Ueno, Makoto;
    • Ikeda, Masafumi;
    • Sugimori, Kazuya;
    • Okano, Naohiro;
    • Shimizu, Kyoko;
    • Yanagimoto, Hiroaki;
    • Okusaka, Takuji;
    • Ozaka, Masato;
    • Todaka, Akiko;
    • Nakamori, Shoji;
    • Tobimatsu, Kazutoshi;
    • Sata, Naohiro
    Publication type:
    Article
    19

    Outcomes of pancreatic cancer with liver oligometastasis.

    Published in:
    Journal of Hepato -- Biliary -- Pancreatic Sciences, 2023, v. 30, n. 2, p. 229, doi. 10.1002/jhbp.1184
    By:
    • Takeda, Tsuyoshi;
    • Sasaki, Takashi;
    • Okamoto, Takeshi;
    • Kasuga, Akiyoshi;
    • Matsuyama, Masato;
    • Ozaka, Masato;
    • Inoue, Yosuke;
    • Takahashi, Yu;
    • Saiura, Akio;
    • Sasahira, Naoki
    Publication type:
    Article
    20
    21
    22
    23

    Improved survival with combined gemcitabine and S-1 for locally advanced pancreatic cancer: pooled analysis of three randomized studies.

    Published in:
    Journal of Hepato -- Biliary -- Pancreatic Sciences, 2014, v. 21, n. 10, p. 761, doi. 10.1002/jhbp.130
    By:
    • Yanagimoto, Hiroaki;
    • Ishii, Hiroshi;
    • Nakai, Yousuke;
    • Ozaka, Masato;
    • Ikari, Takaaki;
    • Koike, Kazuhiko;
    • Ueno, Hideki;
    • Ioka, Tatsuya;
    • Satoi, Sohei;
    • Sho, Masayuki;
    • Okusaka, Takuji;
    • Tanaka, Masao;
    • Shimokawa, Toshio;
    • Kwon, A‐Hon;
    • Isayama, Hiroyuki
    Publication type:
    Article
    24
    25

    Prediction model for pancreatic cancer risk in the general Japanese population.

    Published in:
    PLoS ONE, 2018, v. 13, n. 9, p. 1, doi. 10.1371/journal.pone.0203386
    By:
    • Nakatochi, Masahiro;
    • Lin, Yingsong;
    • Ito, Hidemi;
    • Hara, Kazuo;
    • Kinoshita, Fumie;
    • Kobayashi, Yumiko;
    • Ishii, Hiroshi;
    • Ozaka, Masato;
    • Sasaki, Takashi;
    • Sasahira, Naoki;
    • Morimoto, Manabu;
    • Kobayashi, Satoshi;
    • Ueno, Makoto;
    • Ohkawa, Shinichi;
    • Egawa, Naoto;
    • Kuruma, Sawako;
    • Mori, Mitsuru;
    • Nakao, Haruhisa;
    • Wang, Chaochen;
    • Nishiyama, Takeshi
    Publication type:
    Article
    26

    Comparison of gemcitabine-based chemotherapies for advanced biliary tract cancers by renal function: an exploratory analysis of JCOG1113.

    Published in:
    Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-92166-3
    By:
    • Ueno, Makoto;
    • Morizane, Chigusa;
    • Okusaka, Takuji;
    • Mizusawa, Junki;
    • Kataoka, Tomoko;
    • Ikeda, Masafumi;
    • Ozaka, Masato;
    • Okano, Naohiro;
    • Sugimori, Kazuya;
    • Todaka, Akiko;
    • Shimizu, Satoshi;
    • Mizuno, Nobumasa;
    • Yamamoto, Tomohisa;
    • Sano, Keiji;
    • Tobimatsu, Kazutoshi;
    • Katanuma, Akio;
    • Miyamoto, Atsushi;
    • Yamaguchi, Hironori;
    • Nishina, Tomohiro;
    • Shirakawa, Hirofumi
    Publication type:
    Article
    27
    28
    29
    30

    Development of a nomogram to predict survival in advanced biliary tract cancer.

    Published in:
    Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-48889-6
    By:
    • Imaoka, Hiroshi;
    • Ikeda, Masafumi;
    • Nomura, Shogo;
    • Morizane, Chigusa;
    • Okusaka, Takuji;
    • Ozaka, Masato;
    • Shimizu, Satoshi;
    • Yamazaki, Kentaro;
    • Okano, Naohiro;
    • Sugimori, Kazuya;
    • Shirakawa, Hirofumi;
    • Mizuno, Nobumasa;
    • Satoi, Sohei;
    • Yamaguchi, Hironori;
    • Sugimoto, Rie;
    • Gotoh, Kunihito;
    • Sano, Keji;
    • Asagi, Akinori;
    • Nakamura, Kazuyoshi;
    • Ueno, Makoto
    Publication type:
    Article
    31
    32
    33

    Impact of UGT1A1 genetic polymorphism on toxicity in unresectable pancreatic cancer patients undergoing FOLFIRINOX.

    Published in:
    Cancer Science, 2019, v. 110, n. 2, p. 707, doi. 10.1111/cas.13883
    By:
    • Shirasu, Hiromichi;
    • Todaka, Akiko;
    • Omae, Katsuhiro;
    • Fujii, Hirofumi;
    • Mizuno, Nobumasa;
    • Ozaka, Masato;
    • Ueno, Hideki;
    • Kobayashi, Satoshi;
    • Uesugi, Kazuhiro;
    • Kobayashi, Noritoshi;
    • Hayashi, Hideyuki;
    • Sudo, Kentaro;
    • Okano, Naohiro;
    • Horita, Yosuke;
    • Kamei, Keiko;
    • Yukisawa, Seigo;
    • Kobayashi, Marina;
    • Fukutomi, Akira
    Publication type:
    Article
    34
    35
    36

    Randomized phase II study of gemcitabine and S-1 combination versus gemcitabine alone in the treatment of unresectable advanced pancreatic cancer (Japan Clinical Cancer Research Organization PC-01 study).

    Published in:
    Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 5, p. 1197, doi. 10.1007/s00280-012-1822-1
    By:
    • Ozaka, Masato;
    • Matsumura, Yuji;
    • Ishii, Hiroshi;
    • Omuro, Yasushi;
    • Itoi, Takao;
    • Mouri, Hisatsugu;
    • Hanada, Keiji;
    • Kimura, Yasutoshi;
    • Maetani, Iruru;
    • Okabe, Yoshinobu;
    • Tani, Masaji;
    • Ikeda, Takaaki;
    • Hijioka, Susumu;
    • Watanabe, Ryouhei;
    • Ohoka, Shinya;
    • Hirose, Yuki;
    • Suyama, Masafumi;
    • Egawa, Naoto;
    • Sofuni, Atsushi;
    • Ikari, Takaaki
    Publication type:
    Article
    37
    38
    39
    40

    Correction to: ASO Visual Abstract: Optimizing the Indications for Conversion Surgery Based on an Analysis of 454 Consecutive Japanese Cases with Unresectable Pancreatic Cancer Who Received Modified FOLFIRINOX or Gemcitabine Plus Nab-paclitaxel: A Single-Center Retrospective Study

    Published in:
    2022
    By:
    • Ushida, Yuta;
    • Inoue, Yosuke;
    • Oba, Atsushi;
    • Mie, Takafumi;
    • Ito, Hiromichi;
    • Ono, Yoshihiro;
    • Sato, Takafumi;
    • Ozaka, Masato;
    • Sasaki, Takashi;
    • Saiura, Akio;
    • Sasahira, Naoki;
    • Takahashi, Yu
    Publication type:
    Correction Notice
    41
    42

    ASO Author Reflections: What are the Indications for Conversion Surgery for Initially Unresectable Pancreatic Cancer Who Received Modified FOLFIRINOX or Gemcitabine Plus Nab-paclitaxel? Is Surgery Really Worthwhile after Sufficient Chemotherapy?

    Published in:
    Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2022, v. 29, n. 8, p. 5051, doi. 10.1245/s10434-022-11621-1
    By:
    • Ushida, Yuta;
    • Inoue, Yosuke;
    • Oba, Atsushi;
    • Mie, Takafumi;
    • Ito, Hiromichi;
    • Ono, Yoshihiro;
    • Sato, Takafumi;
    • Ozaka, Masato;
    • Sasaki, Takashi;
    • Saiura, Akio;
    • Sasahira, Naoki;
    • Takahashi, Yu
    Publication type:
    Article
    43

    Optimizing Indications for Conversion Surgery Based on Analysis of 454 Consecutive Japanese Cases with Unresectable Pancreatic Cancer Who Received Modified FOLFIRINOX or Gemcitabine Plus Nab-paclitaxel: A Single-Center Retrospective Study.

    Published in:
    Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2022, v. 29, n. 8, p. 5038, doi. 10.1245/s10434-022-11503-6
    By:
    • Ushida, Yuta;
    • Inoue, Yosuke;
    • Oba, Atsushi;
    • Mie, Takafumi;
    • Ito, Hiromichi;
    • Ono, Yoshihiro;
    • Sato, Takafumi;
    • Ozaka, Masato;
    • Sasaki, Takashi;
    • Saiura, Akio;
    • Sasahira, Naoki;
    • Takahashi, Yu
    Publication type:
    Article
    44

    Genome-wide association meta-analysis identifies GP2 gene risk variants for pancreatic cancer.

    Published in:
    Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-16711-w
    By:
    • Lin, Yingsong;
    • Nakatochi, Masahiro;
    • Hosono, Yasuyuki;
    • Ito, Hidemi;
    • Kamatani, Yoichiro;
    • Inoko, Akihito;
    • Sakamoto, Hiromi;
    • Kinoshita, Fumie;
    • Kobayashi, Yumiko;
    • Ishii, Hiroshi;
    • Ozaka, Masato;
    • Sasaki, Takashi;
    • Matsuyama, Masato;
    • Sasahira, Naoki;
    • Morimoto, Manabu;
    • Kobayashi, Satoshi;
    • Fukushima, Taito;
    • Ueno, Makoto;
    • Ohkawa, Shinichi;
    • Egawa, Naoto
    Publication type:
    Article
    45
    46
    47
    48

    Influence of major hepatectomy on gemcitabine-based chemotherapy for recurrent biliary tract cancer after surgery: a subgroup analysis of JCOG1113.

    Published in:
    International Journal of Clinical Oncology, 2025, v. 30, n. 1, p. 83, doi. 10.1007/s10147-024-02642-9
    By:
    • Okuno, Tatsuya;
    • Morizane, Chigusa;
    • Mizusawa, Junki;
    • Yanagimoto, Hiroaki;
    • Kobayashi, Satoshi;
    • Imaoka, Hiroshi;
    • Terashima, Takeshi;
    • Kawakami, Hisato;
    • Sano, Yusuke;
    • Okusaka, Takuji;
    • Ikeda, Masafumi;
    • Ozaka, Masato;
    • Miwa, Haruo;
    • Todaka, Akiko;
    • Shimizu, Satoshi;
    • Mizuno, Nobumasa;
    • Sekimoto, Mitsugu;
    • Sano, Keiji;
    • Tobimatsu, Kazutoshi;
    • Katanuma, Akio
    Publication type:
    Article
    49

    English version of Japanese Clinical Practice Guidelines 2022 for gastrointestinal stromal tumor (GIST) issued by the Japan Society of Clinical Oncology.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 6, p. 647, doi. 10.1007/s10147-024-02488-1
    By:
    • Hirota, Seiichi;
    • Tateishi, Ukihide;
    • Nakamoto, Yuji;
    • Yamamoto, Hidetaka;
    • Sakurai, Shinji;
    • Kikuchi, Hirotoshi;
    • Kanda, Tatsuo;
    • Kurokawa, Yukinori;
    • Cho, Haruhiko;
    • Nishida, Toshirou;
    • Sawaki, Akira;
    • Ozaka, Masato;
    • Komatsu, Yoshito;
    • Naito, Yoichi;
    • Honma, Yoshitaka;
    • Takahashi, Fumiaki;
    • Hashimoto, Hironobu;
    • Udo, Midori;
    • Araki, Minako;
    • Nishidate, Sumito
    Publication type:
    Article
    50

    Clinical Practice Guidelines for Pancreatic Cancer 2022 from the Japan Pancreas Society: a synopsis.

    Published in:
    International Journal of Clinical Oncology, 2023, v. 28, n. 4, p. 493, doi. 10.1007/s10147-023-02317-x
    By:
    • Okusaka, Takuji;
    • Nakamura, Masafumi;
    • Yoshida, Masahiro;
    • Kitano, Masayuki;
    • Ito, Yoshinori;
    • Mizuno, Nobumasa;
    • Hanada, Keiji;
    • Ozaka, Masato;
    • Morizane, Chigusa;
    • Takeyama, Yoshifumi;
    • Sakamoto, Yasunari;
    • Inoue, Dai;
    • Kamata, Ken;
    • Kawai, Manabu;
    • Kanno, Atsushi;
    • Serikawa, Masahiro;
    • Sofuni, Atsushi;
    • Takayama, Yukiko;
    • Matsubayashi, Hiroyuki;
    • Ohtsuka, Takao
    Publication type:
    Article